Profiling Cumulative Proportional Reporting Ratios of Drug-Induced Liver Injury in the FDA Adverse Event Reporting System (FAERS) Database

Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury

(2011) Eric S. Orman et al.   Clinical Gastroenterology and Hepatology

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™

(2010) Ayako Suzuki et al.   DRUG SAFETY

Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop

(2010) Robert J. Fontana et al.   HEPATOLOGY

Mechanisms of Pathogenesis in Drug Hepatotoxicity Putting the Stress on Mitochondria

(2010) D. P. Jones et al.   MOLECULAR INTERVENTIONS

Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)

(2009) Joyce Weaver et al.   Dermatologic Therapy

Case series of liver failure associated with rosiglitazone and pioglitazone

(2009) James S. Floyd et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDA

(2008) Joyce Weaver et al.   AAPS Journal

Review article: the use of potentially hepatotoxic drugs in patients with liver disease

(2008) N. K. GUPTA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Assessment of drug-induced liver injury in clinical practice

(2008) Ma Isabel Lucena et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

(2008) Allen D. Brinker et al.   HEPATOLOGY

Using controlled clinical trials to learn more about acute drug-induced liver injury

(2008) Paul B. Watkins et al.   HEPATOLOGY

Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis

(2008) Mara McAdams et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect

(2008) Mara A. McAdams et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY